Czech National Bank’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
CWP
DADC
Czech National Bank's PFE Position: Q2 2026 in Review
Czech National Bank increased its Pfizer (PFE) stake by 4.8% in Q2 2026, buying an estimated $1.93M and bringing the position to 1,622,280 shares worth $39.1M. The position accounts for 0.21% of the portfolio, ranked #83.
Czech National Bank first reported a position in PFE in Q3 2022 and has held it in 16 quarters since. The position peaked at $43.5M in Q1 2026. 1,090 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Czech National Bank held 1,622,280 shares of Pfizer worth $39.1M as of Q2 2026.
- Czech National Bank bought 73,802 Pfizer shares in Q2 2026, an estimated $1.93M.
- Pfizer made up 0.21% of Czech National Bank's portfolio in Q2 2026, its #83 holding.
- Czech National Bank first reported a position in Pfizer in Q3 2022 and has held it in 16 quarters since.
- Czech National Bank's Pfizer position peaked at $43.5M in Q1 2026.
- 1,090 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Czech National Bank's 13F filing for Q2 2026, filed 8 Jul 2026.